VTVT logo

VTv Therapeutics (VTVT) Shareholders Equity

Annual Shareholders Equity

-$24.68 M
-$13.94 M-129.80%

December 31, 2023


Summary


Performance

VTVT Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTVTbalance sheetmetrics:

Quarterly Shareholders Equity

$15.01 M
-$1.47 M-8.90%

September 30, 2024


Summary


Performance

VTVT Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTVTbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

VTVT Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-129.8%-8.9%
3 y3 years+69.2%+159.4%
5 y5 years+70.2%+121.6%

VTVT Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-153.4%at low-27.8%+159.4%
5 y5-year-153.4%+69.2%-27.8%+118.7%
alltimeall time-153.4%+91.9%-27.8%+109.9%

VTv Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$15.01 M(-8.9%)
Jun 2024
-
$16.48 M(-20.8%)
Mar 2024
-
$20.80 M(-184.3%)
Dec 2023
-$24.68 M(+129.8%)
-$24.68 M(-2.2%)
Sep 2023
-
-$25.23 M(-0.2%)
Jun 2023
-
-$25.28 M(+31.7%)
Mar 2023
-
-$19.19 M(+78.7%)
Dec 2022
-$10.74 M(+10.3%)
-$10.74 M(-35.2%)
Sep 2022
-
-$16.57 M(+94.3%)
Jun 2022
-
-$8.53 M(+5.4%)
Mar 2022
-
-$8.09 M(-16.9%)
Dec 2021
-$9.74 M(-87.8%)
-$9.74 M(-54.8%)
Sep 2021
-
-$21.55 M(-54.9%)
Jun 2021
-
-$47.82 M(-15.0%)
Mar 2021
-
-$56.27 M(-29.7%)
Dec 2020
-$80.10 M(+63.4%)
-$80.10 M(+55.9%)
Sep 2020
-
-$51.37 M(-26.1%)
Jun 2020
-
-$69.53 M(+12.5%)
Mar 2020
-
-$61.82 M(+26.1%)
Dec 2019
-$49.02 M
-$49.02 M(+4.0%)
DateAnnualQuarterly
Sep 2019
-
-$47.15 M(-5.5%)
Jun 2019
-
-$49.90 M(-13.6%)
Mar 2019
-
-$57.73 M(-30.3%)
Dec 2018
-$82.85 M(-45.1%)
-$82.85 M(+88.4%)
Sep 2018
-
-$43.98 M(-38.6%)
Jun 2018
-
-$71.60 M(-51.9%)
Mar 2018
-
-$148.79 M(-1.5%)
Dec 2017
-$151.05 M(+66.1%)
-$151.05 M(+10.8%)
Sep 2017
-
-$136.30 M(+28.1%)
Jun 2017
-
-$106.41 M(-13.8%)
Mar 2017
-
-$123.47 M(+35.8%)
Dec 2016
-$90.94 M(+16.6%)
-$90.94 M(-18.2%)
Sep 2016
-
-$111.24 M(+39.9%)
Jun 2016
-
-$79.52 M(+26.2%)
Mar 2016
-
-$63.02 M(-19.2%)
Dec 2015
-$77.97 M(+28.4%)
-$77.97 M(-17.2%)
Sep 2015
-
-$94.19 M(+16.4%)
Jun 2015
-
-$80.94 M(+14.8%)
Mar 2015
-
-$70.53 M(+16.2%)
Dec 2014
-$60.72 M(-80.0%)
-$60.72 M
Dec 2013
-$303.73 M
-

FAQ

  • What is vTv Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for vTv Therapeutics?
  • What is vTv Therapeutics annual shareholders equity year-on-year change?
  • What is vTv Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for vTv Therapeutics?
  • What is vTv Therapeutics quarterly shareholders equity year-on-year change?

What is vTv Therapeutics annual stockholders equity?

The current annual shareholders equity of VTVT is -$24.68 M

What is the all time high annual shareholders equity for vTv Therapeutics?

vTv Therapeutics all-time high annual stockholders equity is -$9.74 M

What is vTv Therapeutics annual shareholders equity year-on-year change?

Over the past year, VTVT annual stockholders equity has changed by -$13.94 M (-129.80%)

What is vTv Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of VTVT is $15.01 M

What is the all time high quarterly shareholders equity for vTv Therapeutics?

vTv Therapeutics all-time high quarterly stockholders equity is $20.80 M

What is vTv Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, VTVT quarterly stockholders equity has changed by -$1.47 M (-8.90%)